Mission Statement

Pharmaceutical Value (pValue)’s mission is to apply and test novel methods to improve pharmaceutical coverage and reimbursement decision-making. ​

Team

Partners with pValue


syreon

Traditional measures of value used in cost-effectiveness analyses are not, by definition, fully comprehensive or sufficiently flexible to allow for the inclusion of all the criteria that patients, payers, clinicians, or other health care stakeholders care about. Multi-criteria decision analysis (MCDA) offers a scientifically rigorous decision-making tool capable of including multiple criteria that are important to stakeholders. MCDA has been applied in a variety of sectors, such as investment banking and environmental management, but applications in US healthcare decision making have been limited.

MCDA can improve decision making in health care by engaging key stakeholders and by capturing and weighing criteria not found in traditional measures of value, for example novelty, severity of disease, quality of evidence, and family burden. By encouraging a comprehensive understanding of value, MCDA offers an opportunity to systematically weigh non-traditional aspects of value that fall outside traditional measures of value.​​​​

clear-path-pvalue

Publications

Press

phrma-foundation

CU Anschutz investigators receive PhRMA Foundation Award
Featuring Dr. Brett McQueen and Dr. Jon Campbell